Skip to main content
SpringerLink
Log in

Adalimumab/infliximab

Minimal change nephrotic syndrome and respiratory disorders: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • James B, et al. Case report: Minimal change nephrotic syndrome associated with adalimumab therapy in a pediatric patient with crohn's disease. Inflammatory Bowel Diseases 20: S77, Dec 2014. Available from: URL: http://doi.org/10.1097/01.MIB.0000456850.78401.e5 - USA

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab/infliximab. Reactions Weekly 1545, 16 (2015). https://doi.org/10.1007/s40278-015-9107-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-015-9107-1

Search

Navigation